Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02504554Phase 2Completed
Phase 2, open-label trial in Gastrointestinal disorder and Autism Spectrum Disorder (ASD), sponsored by Arizona State University. Primary endpoint: Gastrointestinal Symptom Rating Scale at 10 weeks. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02504554.